Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Prior to this, Rajdeep served as the Director at GHL Pharma & Diagnostics of Medanta Labs

e4m by e4m Staff
Published: Jan 5, 2026 12:22 PM  | 2 min read
Rajdeep Panwar appointed Chief Commercial Officer at Thyrocare
  • e4m Twitter
  • Thyrocare Technologies Limited has appointed Rajdeep Panwar as Chief Commercial Officer (CCO), effective immediately.
  • Rajdeep has a strong background in P&L management, business expansion, and strategic planning, having previously served as Director at GHL Pharma & Diagnostics Ltd.
  • His past leadership roles include positions at Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs, contributing to his extensive experience in the diagnostics sector.
  • The appointment is part of Thyrocare's strategy to strengthen its leadership team and enhance its market approach, as stated by Rahul Guha, Managing Director and CEO of API Holdings.

Thyrocare Technologies Limited has appointed Rajdeep Panwar as its Chief Commercial Officer (CCO).

Rajdeep brings extensive experience in P&L management, multi-market business expansion, strategic planning and scaling large, multi-centre diagnostic operations.

Prior to this, Rajdeep served as the Director at GHL Pharma & Diagnostics Ltd. (GHL–Medanta), where he played a key role in expanding Medanta Labs across North India.
He has also held leadership roles at organisations such as Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs.

Commenting on his appointment, Rajdeep Panwar, Chief Commercial Officer of Thyrocare, stated, “I am excited to join Thyrocare at a pivotal phase of its growth. The company’s mission to make high-quality diagnostics affordable and accessible across India strongly resonates with me. With its deep partner network and strong scientific foundation, Thyrocare is well positioned to get closer to patients and drive meaningful impact at scale.”

Rahul Guha, Managing Director and CEO of API Holdings, said, “As Thyrocare continues to scale, strengthening our leadership team is critical, and particularly having strong commercial leadership is key. Rajdeep brings deep experience in building and expanding diagnostics businesses in India. We believe his leadership will help strengthen our market approach and deepen engagement with customers and partners. In combination with Dr. Kinha, who recently joined us as Chief Operating Officer (COO) and brings deep operational and quality expertise, the Thyrocare leadership team is best in class and well positioned to win in this growing market.”

Published On: Jan 5, 2026 12:22 PM